Browsing: Shows

In an interim analysis of the phase III ELEVATE trial reported in The New England Journal of Medicine, Yue et al found that patients with completely resected ALK-positive non–small cell lung cancer (NSCLC) who received adjuvant ensartinib experienced significantly longer disease-free survival than those receiving placebo. The investigators conducted the study to determine whether the…

If you or someone you know is thinking of harming themselves, the National Suicide Prevention Lifeline provides free support at 1-800-273-8255. U.S. residents can also be connected to the Lifeline bycalling or texting 988 or chatting at988lifeline.org. For more about risk factors and warning signs, visit the organization’sofficial website